1st Quarter - Report
HARBINGER STRATEGIES, LLC for GENENTECH, INC.
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to corporate taxation including corporate rate; deductibility of research and development expenses; and international taxation (Foreign Derived Intangible Income). P.L. 119-21.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN LEGANSKI | — |
| KYLE NEVINS | — |
| MANNY ROSSMAN | — |
| JONATHAN SLEMROD | — |
| STEVE STOMBRES | — |
Health Issues HCR
Issues related to drug pricing. Issues related to the 340B Drug Discount Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN LEGANSKI | — |
| KYLE NEVINS | — |
| MANNY ROSSMAN | — |
| JONATHAN SLEMROD | — |
| STEVE STOMBRES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.